Mankind Pharma shares hit upper circuit on listing

Mankind Pharma shares listed at a 25% premium on NSE, hitting upper circuit. The stock opened at ₹1,250 against an issue price of ₹930, reflecting strong retail investor demand. Block deals worth ₹1,200 crore were executed post-listing. Market sentiment remains bullish on robust primary sales traction in the dermatology and generics segment.

📊 STOCKS: $MANKIND | 🏢 SECTOR: Pharma | #HIGHIMPACT #IPO